TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMRX

Immuneering Corp

Healthcare · Biotechnology

4.40$ -0.9% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMRX
Line item 2019 2020 2021 2022 2023 2024 2025
+172.5% +333.9% -26.6% -16.2% -48.6% +340.1%
+168.3% +303.7% -28.6% -18.1% -55.6% +345.2%
+169.1% +101.9% -3.0% -18.2% -39.2% +255.9%
+169.1% +302.3% -29.3% -18.8% -57.8% +378.2%
+138.2% -50.8% -95.0% -100.0%
+1,820.5% +19.2% +69.7%
-0.2% +0.0% +0.0% +0.0%
-6.8% -7.2% -7.7% -8.4%
+195.3% -82.4% +16.7% -4.1% -5.7% +19.2%
+346.4% +149.7% +43.0% -2.6% -4.4% +34.2%
+259.1% +38.2% -20.8% +12.8% +17.3%
+402.0% -5.8% +126.2% -33.1% -7.3% -21.2%
-29.6% -17.5% -54.3% +427.9%
+0.0% +94.8% +0.3% +7.7% +5.5% +46.8%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?